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Non-technical summary: 
• Increases in aerobic capacity and intramuscular triglyceride (IMTG) utilization are well-described 
adaptations to endurance training (ET) and contribute to improvements in insulin sensitivity.  
• Sprint interval training (SIT) also improves aerobic capacity and insulin sensitivity with a lower time 
commitment than ET. 
• This study aimed to determine whether SIT also induces improvements in insulin sensitivity and net 
IMTG breakdown, and to investigate the underlying mechanisms.  
• Six weeks of ET and SIT increased net IMTG breakdown during moderate-intensity cycling and 
improved insulin sensitivity. A greater concentration of lipid droplet-associated proteins, perilipin 2 
and perilipin 5, was observed following both training modes and contributes to the increases in net 
IMTG breakdown following training.   
• The results suggest a novel mechanism for the training-induced improvements in IMTG breakdown 
and insulin sensitivity, and clearly demonstrate that SIT is an alternative, time-efficient training 
strategy that induces similar beneficial metabolic adaptations. 
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Abstract 
Intramuscular triglyceride (IMTG) utilization is enhanced by endurance training (ET) and is linked to improved 
insulin sensitivity. This study first investigated the hypothesis that ET-induced increases in net IMTG 
breakdown and insulin sensitivity are related to increased expression of perilipin 2 (PLIN2) and perilipin 5 
(PLIN5). Secondly, we hypothesized that sprint interval training (SIT) also promotes increases in IMTG 
utilization and insulin sensitivity.  Sixteen sedentary males performed 6 weeks of either SIT (4-6, 30s 
Wingate tests per session, 3d.week-1) or ET (40-60 min moderate-intensity cycling, 5d.week-1). Training 
increased resting IMTG content (SIT 1.7-fold, ET 2.4-fold; P<0.05) concomitant with parallel increases in 
PLIN2 (SIT 2.3-fold, ET 2.8-fold; P<0.01) and PLIN5 expression (SIT 2.2-fold, ET 3.1-fold; P<0.01). Pre-
training, 60 min cycling at ~65% pre-training VO2peak decreased IMTG content in type I fibres (SIT 17±10%, 
ET 15±12%; P<0.05). Following training, a significantly greater breakdown of IMTG in type I fibres occurred 
during exercise (SIT 27±13%, ET 43±6%; P<0.05), with preferential breakdown of PLIN2- and particularly 
PLIN5-associated lipid droplets. Training increased the Matsuda insulin sensitivity index (SIT 56±15%, ET 
29±12%, main effect P<0.05). No training x group interactions were observed for any variables. In 
conclusion, SIT and ET both increase net IMTG breakdown during exercise and similar increases in PLIN2 
and PLIN5 protein expression. The data are consistent with the hypothesis that increases in PLIN2 and 
PLIN5 are related to the mechanisms that promote increased IMTG utilization during exercise and 
improvements in insulin sensitivity following 6 weeks SIT and ET. 
 
 
 
Abbreviations list: 
ATGL, adipose triglyceride lipase; CGI-58, comparative gene identification-58; CHO, Chinese hamster ovary; 
DAG, diacylglycerol; DXA, Dual energy X-ray Absorptiometry; ET, endurance training; SIT, sprint interval 
training; HSL, hormone-sensitive lipase; IMTG, intramuscular triglyceride; LD, lipid droplet; OGTT, oral 
glucose tolerance test; PLIN2, perilipin 2; PLIN5, perilipin 5.  
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Introduction 
High intramuscular triglyceride (IMTG) concentrations are associated with insulin resistance in sedentary 
obese individuals and type 2 diabetes patients (Phillips et al., 1996; Pan et al., 1997; Goodpaster et al., 
2001). However, the athletes’ paradox describes a state of elevated IMTG storage alongside high levels of 
insulin sensitivity in endurance trained athletes (Goodpaster et al., 2001; van Loon et al., 2004). Endurance 
training also increases oxidative capacity and promotes a shift towards greater IMTG utilization during 
exercise (Schrauwen et al., 2002). Therefore, the capacity to oxidise IMTG as a fuel source is believed to be 
mechanistically important for the preservation of high insulin sensitivity in the face of elevated intramuscular 
lipid storage (Goodpaster et al., 2001; Bruce et al., 2003; van Loon & Goodpaster, 2006). The overriding 
current hypothesis is that high rates of IMTG oxidation during exercise allows the regular turnover of the 
intramuscular lipid pool and prevents the accumulation of fatty acid metabolites, such as long-chain acyl-
CoA, diacylglycerol and ceramides, which are believed to blunt insulin sensitivity (van Loon & Goodpaster, 
2006; Moro et al., 2008; Shaw et al., 2010). Therefore, understanding the mechanisms regulating IMTG 
lipolysis and IMTG-derived FA oxidation during exercise remain important.  
 
Recent attention has focused on the role of the perilipins (PLINs), a family of lipid droplet (LD) proteins, of 
which perilipin 2 (PLIN2) and 5 (PLIN5) are expressed in skeletal muscle, but who’s precise role is not fully 
understood. PLIN2 is ubiquitously expressed in the human body (Brasaemle et al., 1997) and its content is 
~2-fold higher in type I muscle fibres compared to type II fibres, which mirrors the fibre type distribution of 
IMTG (Shaw et al., 2009). In non-muscle cells, PLIN2 expression regulates basal lipolytic rates in vitro by 
limiting the interaction of adipose triglyceride lipase (ATGL) with the LD (Listenberger et al., 2007; Bell et al., 
2008). However, in intact rat skeletal muscle in response to lipolytic stimuli (electrically induced contractions 
and adrenaline) there is an increase in colocalisation of hormone sensitive lipase (HSL) with PLIN2 and of 
HSL with LDs (Prats et al., 2006). Furthermore, we recently reported that PLIN2-containing LDs are depleted 
in human skeletal muscle during moderate intensity exercise (Shepherd et al., 2012). PLIN5, on the other 
hand, is highly expressed in oxidative tissues (Wolins et al., 2006a; Yamaguchi et al., 2006; Dalen et al., 
2007). Cell culture studies demonstrate that PLIN5 expression limits basal lipolysis more effectively than 
PLIN2 (Wang et al., 2011a). Interestingly, these studies also show that PLIN5 expression (but not PLIN2) 
recruits ATGL and its coactivator, CGI-58, to the LD surface under basal conditions, and it is believed that 
PLIN5 phosphorylation releases CGI-58 to bind ATGL to stimulate lipolysis in response to PKA-activation 
(Wang et al., 2011a). Skeletal muscle PLIN5 expression is higher in athletes (Amati et al., 2011) and 
increases following training in lean and obese individuals (Peters et al., 2012). Collectively, the results from 
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the limited number of studies so far suggest that both PLIN2 and PLIN5 are important in regulating IMTG 
lipolytic rates, but that PLIN5 may be the key PLIN regulating IMTG lipolysis and net IMTG breakdown during 
exercise.  
 
Sprint interval training (SIT) promotes skeletal muscle adaptations and improvements in insulin sensitivity 
comparable to those induced by ET (Burgomaster et al., 2008; Gibala et al., 2012). In particular, skeletal 
muscle oxidative capacity is enhanced following SIT (Burgomaster et al., 2005; Burgomaster et al., 2007; 
Burgomaster et al., 2008; Little et al., 2010; Hood et al., 2011; Little et al., 2011), and may partly explain the 
SIT-induced improvements in whole-body insulin sensitivity (Babraj et al., 2009; Richards et al., 2010; Hood 
et al., 2011; Little et al., 2011).  However, it has yet to be investigated whether such improvements in insulin 
sensitivity occur alongside increases in net IMTG breakdown during exercise and enhanced skeletal muscle 
expression of PLIN2 and PLIN5. 
  
Given the importance of studying IMTG metabolism in a fibre type specific manner (van Loon, 2004), in the 
current study we investigated IMTG metabolism and the content and localization of PLIN2 and PLIN5 
following different training interventions using immunofluorescence microscopy. We hypothesized that 
increased expression of PLIN2 and PLIN5 plays a role in the well-established increase in net IMTG 
breakdown during exercise following ET. In addition, we investigated the hypothesis that SIT also increases 
the capacity to breakdown IMTG during moderate intensity exercise, the protein expression of PLIN2 and 
PLIN5 and insulin sensitivity. 
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Method 
Ethical approval 
Sixteen healthy, sedentary males volunteered to take part in the study (for characteristics see Table 1), 
which was approved by the Black Country NHS Research Ethics Committee (West Midlands, UK) and 
conformed with the Declaration of Helsinki. Written, informed consent was obtained from volunteers following 
a verbal and written explanation of the nature and risks involved in the experimental procedure. All subjects 
were healthy (free of any known metabolic or cardiovascular disease) and engaged in less than two 30 min 
sessions of physical activity per week in the preceding year. Percutaneous muscle biopsies taken in this 
study before and after each training mode, under basal conditions and after 60 min of moderate-intensity 
exercise have been used both for the measurements described in this manuscript and for measurements of 
endothelial eNOS content, eNOS serine1177 phosphorylation, NOX2 content and capillarization.  The latter 
are reported in a parallel manuscript (M. Cocks et al., under review).  Measures such as insulin sensitivity 
and VO2 peak also made in the volunteers are relevant for the interpretation of both studies and are presented 
in both manuscripts.  
 
Pre-experimental procedures 
At least 5 days prior to entering the study subjects performed a progressive exercise test to exhaustion on an 
electronically braked cycle ergometer (Lode BV, Groningen, The Netherlands) in order to determine peak 
oxygen uptake (VO2 peak) using an on-line gas collection system (Oxycon Pro, Jaeger, Germany). The test 
consisted of initially cycling at 95 W, followed by sequential increments of 35 W every 3 minutes until 
cadence was reduced to < 50rpm, at which point the test was terminated. VO2 peak was taken as the highest 
value obtained in the last 30-seconds of the test. During this visit subjects were also allocated to their 
training intervention. The 16 subjects were divided into pairs, with the best possible match for age, BMI and 
VO2 peak, with one member from each pair randomly assigned to SIT and the other to the ET group. As none 
of the volunteers were familiar with SIT exercise, the subjects in the SIT group were familiarised to this 
exercise mode through the performance of one 30 s all out effort (Wingate test, (Bar-Or, 1987)) on a cycle 
ergometer against a load equivalent to 0.075 kg per kg body mass.   
 
Experimental procedures 
Experimental procedures performed before (pre) and after (post) training were identical, and were 
undertaken across two consecutive days. Post-training experimental procedures were performed > 48h after 
the final exercise training session in order to minimize any acute effects of the last exercise training bout. 
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Day 1: All subjects reported to the laboratory after an overnight fast (> 10 h), having been instructed to 
refrain from performing vigorous exercise in the preceding 48 h period. On arrival, a 20G cannula was 
inserted into the antecubital vein of one arm and a 3-way stop cock attached to allow for multiple blood 
sampling and flushing of the cannula. After a 20 mL baseline sample was obtained, subjects consumed a 
beverage containing 75 g glucose (using 82.5g dextrose monohydrate obtained from Roquette, UK)  
dissolved in water made up to 300 ml. Further 5 mL blood samples were obtained after 30, 60, 90 and 120 
minutes, and collected into EDTA-containing vacutainers. Isotonic saline (3 mL) (B Braun, UK) was used to 
keep the cannula patent every 15 minutes during the 2 h test. Plasma samples for each time point were 
obtained through centrifugation (10-minutes at 3500 rpm at 4°C) and stored at -80°C for subsequent 
analysis. Immediately following the oral glucose tolerance test (OGTT), body composition analysis was 
performed using Dual energy X-ray Absorptiometry (DXA). QDR software (Hologic Inc., MA, US) was used to 
analyse fat mass and fat-free mass in individual limbs and the trunk region of each subject. Relative fat mass 
was calculated using absolute fat mass as a proportion of total region mass. 
 
Day 2: On arrival at the laboratory after an overnight fast (> 10 h), the thigh of one leg was prepared for 
muscle biopsy collection. Subjects were randomised as to which leg they received the biopsy from pre-
training; the contralateral leg was sampled post-training. Briefly, local anaesthetic (1% lidocaine, B Braun, 
UK) was administered under the skin and over the fascia of the vastus lateralis before two incisions were 
made approximately 2 cm apart. A muscle biopsy (~100mg) was taken using the Bergstr m technique 
(Bergström, 1975) from the distal incision prior to exercise. Skeletal muscle samples were first blotted to 
remove excess blood, and visible fat and collagen were removed through dissection. A portion of the muscle 
tissue was then prepared for immunohistochemical analysis by embedding in Tissue-Tek OCT Compound 
(Sakura Finetek Europe, The Netherlands) and frozen in liquid nitrogen-cooled isopentane. The remaining 
muscle tissue (~40mg) was snap frozen in liquid nitrogen. Subsequently, subjects underwent 60 min of 
steady state exercise on an electronically braked cycle ergometer set at a workload equivalent to 65% pre-
training VO2 peak. Heart rate and rate of perceived exertion (RPE) were recorded every 5 minutes, while gas 
collection (5 min collection period) was performed at 15 minute intervals (t = 15, 30, 45, 60 min) using an on-
line gas collection system (Oxycon Pro, Jaeger, Germany), in order to determine rates of carbohydrate and 
fat oxidation. A second muscle biopsy was taken immediately post-exercise from the proximal incision. 
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For all experimental trials, subjects were provided with all food and drinks to be consumed in the preceding 
24 h period. The diet was of a standard macronutrient composition (50% carbohydrate, 35% fat, 15% 
protein), but adjusted for each individuals habitual energy intake, assessed through the completion of 3 day 
diet diary. When completing diet diaries, subjects were provided with electronic scales in order to increase 
the accuracy of portion size determination. All subjects were asked to continue their habitual dietary and 
physical activity patterns during the training period, again completing a 3 day diet diary post-training in order 
to assess any differences in energy or macronutrient intake over the training period. 
 
Training interventions 
Sprint Interval Training (SIT): The SIT training protocol was similar to the protocol used by Burgomaster et al 
(Burgomaster et al., 2008). Subjects performed 30 s ‘all out’ sprints (Wingate test) on a cycle ergometer 
against a load equivalent to 0.075 kg per kg body mass and with 4.5 minutes recovery between each test. 
During the recovery period subjects cycled against a small load (30 W) maintaining a cadence of below 50 
rpm. All participants trained 3 times a week for 6 weeks, and were excluded from the study if they were 
absent from more than 2 sessions. Initially participants performed 4 Wingate tests per training session, 
increasing to 5 tests in weeks 3 and 4, and finishing with 6 tests per session in weeks 5 and 6. 
 
Endurance Training (ET): Subjects in the ET group trained 5 times a week over the 6 week training period, 
and were excluded from the study if they were absent from more than 3 training sessions. All subjects cycled 
at a workload equivalent to ~65% VO2 peak for 40 minutes in the first 2 weeks, increasing to 50 minutes in the 
following 2 weeks, and 60 minutes in the final 2 weeks. VO2 peak was reassessed after 3 weeks of training 
and workload adjusted accordingly. 
 
Muscle sample analysis 
Immunofluorescence staining: Serial 5 µm sections were cut at -30°C on to ethanol-cleaned glass slides.  
Sections were fixed in 3.7% formaldehyde for 1 h, rinsed briefly in deionised water, and permeabilised in 
0.5% Triton-X 100 for 5 min, followed by 3 x 5 min washes in PBS. Subsequently, slides underwent 
incubation with appropriate antibodies for 45 min, after which, a further 3 x 5 min PBS wash preceded 
incubation of sections with appropriately targeted secondary fluorescent conjugated antibodies for 30 min.  
IMTG (lipid droplets) were visualised using neutral lipid dye oil red O staining (Koopman et al., 2001). As 
such, oil red O solution was applied to washed (3 x 5min PBS) sections for 30 min following secondary 
antibody incubation. Slides were then rinsed briefly in deionised water, followed by a 10 min rinse with slow 
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running tap water, after which coverslips were mounted with a glycerol and mowiol 4-88 solution in 0.2 M Tris 
buffer (pH 8.5) (including 0.1% DABCO anti-fade medium). 
 
Cell border visualisation was achieved through incubation of sections with a wheat germ agglutinin Alexa 
Fluor 350 conjugate (Cat. #W11263, Invitrogen, Paisley, UK). Muscle fibre type was determined using a 
mouse anti-myosin antibody for slow twitch fibres (A4.840-c, DSHB, developed by Dr. Blau) followed by the 
application of Alexa Fluor goat anti-mouse IgM 488 or 350. Fibres containing positive staining were classified 
as type I fibres, while those with no staining were classified as type II fibres. The oil red O working solution 
was freshly produced for each staining procedure and consisted of 100 mg oil red O in 20 ml 60% 
triethylphosphate (Sigma-Aldrich, UK). Twelve ml of working solution was added to 8 ml deionised water and 
filtered twice to remove any oil red O crystals. Mitochondria were visualised using a mouse monoclonal anti-
OxPhos Complex IV primary antibody (Cat. #459600, Invitrogen, Paisley, UK), followed by an Alexa Fluor 
goat anti-mouse IgG2a 594 secondary antibody. PLIN2 visualisation was achieved using a mouse 
monoclonal anti-adipophilin primary antibody (Cat. #03-610102, American Research Products, MA, USA), 
followed by an Alexa Fluor goat anti-mouse IgG1 594 secondary antibody. On occasions when IMTG staining 
with oil red O was undertaken in parallel with PLIN2, an Alexa Fluor goat-anti mouse IgG1 488 secondary 
antibody was used. PLIN5 was visualised using a guinea pig polyclonal anti-OXPAT primary antibody (Cat. 
#GP31, Progen Biotechnik, Germany) followed by application of an Alexa Fluor goat-anti guinea pig IgG 488 
secondary antibody. All Alexa Fluor secondary antibodies were obtained from Invitrogen (Paisley, UK). The 
specificity of the PLIN5 antibody was confirmed in a competition experiment in which a PLIN5 recombinant 
peptide (Cat. #NB110-60511PEP, Novus Biologicals, Cambridge, UK) was incubated with the PLIN5 primary 
antibody, subsequently resulting in removal of the positive fluorescent signal for PLIN5 (Supplementary fig. 
1).   
 
Image capture, processing and data analysis: Images of cross-sectional orientated sections were used for 
the determination of fibre-type differences in the content of IMTG, mitochondria, and PLIN2 and PLIN5. 
Images were captured using a Nikon E600 microscope with a 40x 0.75 NA objective, coupled to a SPOT RT 
KE colour 3 shot CCD camera (Diagnostic Instruments Inc., MI, USA).  Both DAPI UV (340-380 nm) and 
FITC (465-495 nm) excitation filters were used to view the Alexa Fluor 350 and 488 fluorophores, 
respectively. In addition, a Texas red (540-580 nm) excitation filter was used to view sections stained with oil 
red O or the Alexa Fluor 594 fluorophore. The use of 3 excitation filters and 1 dichroic and 1 emission filter 
(“Pinkel” Triple Set, Semrock, Kettering, UK) allowed for semi-automated sequential image capture. Digital 
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images to specifically assess the size and number of IMTG and PLIN2 and PLIN5 objects were obtained 
using an inverted confocal microscope (Leica DMIRE2, Leica Microsystems) using a 63x 1.4 NA oil 
immersion objective. An argon laser was used to excite the Alexa Fluor 488 fluorophore, while both the 
Alexa Fluor 594 fluorophore and oil red O was excited using a Helium-Neon laser. The same system was 
used to capture digital images and to assess IMTG and PLIN2 or PLIN5 colocalisation.  
 
Image processing was undertaken using Image-Pro Plus 5.1 software (Media Cybernetics, MD, USA). Fibre-
type distribution of IMTG, PLIN2 and PLIN5 and mitochondria was assessed using widefield images. To this 
end, between 6 and 10 widefield images were used per muscle section, resulting in 104 ± 5 fibres analysed 
per muscle cross-section (42 ± 3 type I fibres, 62 ± 3 type II fibres). Mitochondrial fluorescence staining 
intensity was used to indicate changes in mitochondrial content after training. An intensity threshold was 
uniformly selected to represent a positive signal for IMTG, and PLIN2 and PLIN5. The content of IMTG and 
PLIN2 and PLIN5 were expressed as the positively stained area fraction relative to the total area of each 
muscle fibre. Images captured using confocal microscopy were used to identify changes in mean IMTG, 
PLIN2 and PLIN5 size and density. Density was calculated as the number of IMTG objects relative to area. 
The area of individual IMTG (lipid droplets), PLIN2 or PLIN5 objects was used as a measure of size.    
 
Colocalisation analysis was performed separately for PLIN2 or PLIN5 with IMTG. This analysis was 
restricted to type I fibres as a previous publication from our laboratory has shown that changes in 
colocalisation with IMTG do not occur in type II fibres in response to the exercise bout used in the present 
study (Shepherd et al., 2012). In this respect, sequential images of either PLIN2 or PLIN5 and IMTG were 
captured using confocal microscopy (as described) with 8x digital zoom. Positive signal for either PLIN 
protein and IMTG was obtained through the selection of a uniform intensity threshold. Binary images were 
created based on the selected threshold and subsequently used for colocalisation analysis. A colocalisation 
map was generated, displaying the merged images, with the overlapping area subsequently extracted to 
create a separate binary image. The total number of objects in this image was expressed relative to the total 
number of PLIN2 (or PLIN5) as a measure of colocalisation (Fig. 4).  The extracted objects were also used 
as a measure of the number of PLIN associated-LDs (PLIN-LDs), and the number of extracted objects were 
subsequently subtracted from the total number of LDs to quantify the number of LDs not associated with 
PLIN (PLIN-null-LDs). Several controls were performed to check for bleed through, non specific secondary 
antibody binding and autofluorescence before colocalisation analysis was performed. No positive staining 
was observed in the opposite channel when single staining (IMTG, PLIN2 and PLIN5) was performed and 
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omission of the primary or secondary antibody, and oil red O abolished all positive signal in the relevant 
channel discounting the influence of tissue autofluorescence or non-specific secondary antibody binding. In 
addition, we performed the same colocalisation analysis on a series of non-corresponding PLIN2 (or PLIN5) 
and IMTG images, in order to determine whether the level of random colocalisation was statistically different 
from that obtained for the true corresponding images, as previously described (Lachmanovich et al., 2003).   
 
Western blot analysis: Snap frozen muscle tissue was powdered in liquid nitrogen and transferred to 
eppendorf tubes containing lysis buffer (1x RIPA buffer, Cell Signalling, including 1 complete mini protease 
inhibitor tablet, Roche Diagnostics, Germany). Samples were mixed on ice for 2 hours and then 
homogenized on ice for ~30 s at slow speed (Polytron), followed by centrifugation for 20 min at 4°C and 
10,000 G. The supernatant was removed and a small portion used to determine protein concentration 
(Pierce BCA assay kit). Samples were subsequently diluted to a final concentration of 3 µg.µl-1, using 
homogenization buffer and Laemmli sample buffer (Sigma) and boiled for 5 min. Equal quantities of protein 
(45 µg) were separated by electrophoresis on 12% SDS-polyacrylamide gels and transferred to nitrocellulose 
membranes at 25 V for 1.5 hours. Ponceau S staining was performed to assess transfer efficacy and 
subsequently imaged using a ChemiDoc XRS+ system (Bio-Rad, UK). This image was used to quantify the 
total protein stain of each lane, and this was used as a measure of equal loading when the inter-lane 
variation was less than 10%. Membranes were subsequently destained (0.1M NaOH) and blocked for 1 h in 
5% non-fat dried milk (NFDM) in phosphate-buffered saline with 0.1% Tween (PBST) followed by incubation 
overnight at room temperature with either the anti-adipophilin (Cat. #03-610102, American Research 
Products, MA, USA) or anti-OXPAT (Cat. #GP31, Progen Biotechnik, Germany) primary antibody diluted in 
3% NFDM in PBST. The membranes were then washed 3 times in PBST, blocked in 5% NFDM in PBST for 
1 h, followed by incubation for 1 h at room temperature with appropriate horseradish peroxidase-conjugated 
IgG secondary antibodies diluted in 3% NFDM in PBST. Antibody binding was detected using enhanced 
chemiluminescence HRP detection reagent (GE Healthcare, UK) and imaging and band quantification was 
performed using a ChemiDoc XRS+ system (Bio-Rad, UK). 
 
Blood Sample Analysis 
Plasma glucose concentrations were determined spectrophotometrically using an ILab-600 semi-automatic 
analyzer in combination with the glucose oxidase kit (Instrumentation Laboratory Ltd UK, Warrington, UK).  
Insulin concentrations during the OGTT were determined using a commercially available direct insulin ELISA 
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kit (Invitrogen, Paisley, UK). Insulin sensitivity index (Matsuda & DeFronzo, 1999) was calculated based on 
plasma glucose and insulin values. 
 
Calculations and statistical analysis 
Rates of whole body fat and carbohydrate oxidation (g.min-1) were calculated from the VO2 and VCO2 values 
collected at 15, 30, 45 and 60 minutes during the steady state cycling exercise. The calculations were made 
assuming protein oxidation was negligible, and according to previously published equations (Jeukendrup & 
Wallis, 2005): 
Carbohydrate oxidation (g.min-1) = 4.210·VCO2 – 2.962·VO2 
Fat Oxidation = 1.695·VO2 – 1.701·VCO2 
 
Insulin sensitivity was calculated using the Matsuda index (Matsuda & DeFronzo, 1999), using the following 
equation:  
Matsuda !ISI"= 
10,000
#!FPG $ FPI " (P  P )
 
 
All data are expressed as means ± S.E.M. Significance was set at the 0.05 level of confidence. Changes in 
body composition, exercise capacity, insulin sensitivity and substrate utilization were assessed using a 2-
factor repeated measures ANOVA, with the between-subject factor ‘group’ (SIT vs. ET) and the within-
subject factor ‘training’ (pre- vs. post-training). Changes in mitochondrial density and PLIN2 and 5 content 
were assessed using a mixed 3-factor repeated measures ANOVA using the within-subject factors ‘fibre’ 
(type I versus type II fibres) and ‘training’ and between-subject (group) factor used in the 2-factor analysis. 
To inspect differences in IMTG, we hypothesised a priori that IMTG content would be significantly different 
between type I and type II fibres. Thus, we used a 3-factor repeated measures ANOVA with the between-
subject factor as ‘group’, and the within-subject factor’s ‘training’ and ‘time’ (pre- versus post-exercise). The 
same three-factor repeated measures ANOVA and between-subject and within-subject factors were used 
when assessing differences in colocalisation, following an a priori hypothesis that colocalisation would be 
significantly different between actual and randomised images, based on a previous study (Lachmanovich et 
al., 2003). Significant main effects or interactions were assessed using Bonferroni adjustment post hoc 
analysis. Improvements in training performance (SIT group; e.g. mean power) were examined using a paired 
t test analysis.  A Pearson’s bivariate correlation analysis was used to investigate specific relationships 
between variables.   
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Results 
Exercise capacity, body composition, substrate utilization and insulin sensitivity 
At baseline, no differences between groups were observed for any of the variables mentioned in Table 1. In 
response to training VO2peak was significantly improved irrespective of training type (SIT 7 ± 2%, ET 15 ± 3%, 
main effect for condition, P < 0.001, Table 1). The difference between the modes of exercise did not reach 
statistical significance (P = 0.064). Wmax was also increased after training, with no difference between groups 
(main effect for condition, P < 0.001). Fat free mass increased significantly post-training, with no difference 
between groups (main training effect, P = 0.039). The observed decrease in relative fat mass (Table 1) did 
not reach statistical significance, with no difference between groups (main training effect, P = 0.075). 
Glucose area under the curve (AUC) was reduced post-training (SIT 17 ± 2%, ET 12 ± 2%; main training 
effect, P < 0.001, Table 1), with no difference between groups. Similarly, training reduced insulin AUC (SIT 
33 ± 3%, ET 18 ± 5%; main training effect, P < 0.001, Table 1), with no difference between groups. In 
accordance, training improved insulin sensitivity, calculated using the Matsuda index (Matsuda & DeFronzo, 
1999) (SIT 56 ± 15%, ET 29 ± 12%; main training effect, P < 0.01, Table 1), with no difference between 
groups. Carbohydrate (absolute and relative) and fat (relative only) oxidation, as well as RER, were all 
significantly altered compared to pre-training following ET only (P < 0.05, Table 2), with no effect apparent 
following SIT. RER tended to be lower in the SIT group (P = 0.055) before training. When considering the 
effectiveness of SIT, the first and final training sessions were examined. Specifically, mean power output 
increased during training by 14 ± 3% (P = 0.001) and peak power output increased by 21 ± 6% (P = 0.01).    
 
Analysis of mitochondrial content 
Immunofluorescence images demonstrated that COX protein expression (fluorescence intensity), 
representing mitochondrial density, was greater in type I fibres than type II fibres pre and post-training (main 
effect of fibre; P < 0.001, Table 3). No group differences were apparent at baseline. A main effect of training 
was observed, with increases in mitochondrial density in both type I fibres (SIT 39 ± 4%, ET 46 ± 16%) and 
type II fibres (SIT 39 ± 3%, ET 50 ± 14%; P < 0.05, Table 3). No difference between groups was apparent 
following training. 
 
Intramuscular triglyceride analysis 
Our a priori hypothesis that IMTG content is greater in type I fibres compared to type II fibres meant that we 
examined IMTG fibre-type specific training effects separately. There were no differences in resting IMTG 
content between groups at baseline. A significant main effect of training was observed with increased resting 
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IMTG content in type I fibres after both interventions (expressed as % fibre stained) (SIT 1.9-fold, ET 2.9-
fold, main training effect ; P < 0.05, Fig. 1E). This finding was attributed to a significant rise in IMTG density, 
expressed as the number of LDs per area, after SIT (pre-training, 0.065 ± 0.009; post-training, 0.087 ± 0.010 
µm2) and ET (pre-training, 0.064 ± 0.009; post-training, 0.109 ± 0.012 µm2). A main effect of training was 
observed for IMTG content in type II fibres after both interventions (SIT 1.4-fold, ET 2.5-fold, main training 
effect, P < 0.05, Fig. 1F).  This increase in IMTG content was again attributable to an increase in IMTG 
density. No changes in IMTG size were observed in response to training. There were no interaction effects 
between training and group in any of the measures of resting IMTG content. 
 
Before training, absolute IMTG content in type I fibres decreased significantly in response to 60 min steady 
state cycling, with no difference between groups (SIT 17 ± 9%, ET 15 ± 12%, main effect of time; P < 0.05, 
Fig. 1E). Following training, net IMTG breakdown during exercise in type I fibres was also significantly 
increased (SIT 27 ± 13%, ET 43 ± 5%; main effect of time; P < 0.05, Fig. 1E). In comparison to pre-training, 
net IMTG breakdown in type I fibres was significantly greater following training (training x time interaction; P 
< 0.05) with no difference in net IMTG breakdown between groups. Both pre- and post-training, the reduction 
in IMTG content in type I fibres was attributed to decreases in IMTG density after SIT (pre-training, 21 ± 
13%; post-training, 38 ± 7%) and ET (pre-training, 20 ± 17%; post-training, 32 ± 8%). No significant 
breakdown of IMTG occurred during the exercise bout in type II fibres either before or after training (Fig. 1F).  
 
PLIN2 and PLIN5 analysis 
Immunofluorescence images show that PLIN2 content (expressed as % fibre stained) in type I fibres was 
significantly greater than in type II fibres both before and following training, irrespective of intervention (P < 
0.001, Fig. 2C & D). A main effect of training was observed, with an increase in PLIN2 content in both type I 
(SIT 2.1-fold, ET 3.4-fold, Fig. 2C & D) and type II fibres (SIT 2.5-fold, ET 2.2-fold, main training effect, P < 
0.001). This finding was attributed to an increase in PLIN2 density in both type I (SIT: pre 0.057 ± 0.008, post 
0.092 ± 0.010 µm2, ET: pre 0.051 ± 0.012, post 0.100 ± 0.009 µm2) and type II fibres (SIT: pre 0.020 ± 0.004, 
post 0.044 ± 0.009 µm2, ET: pre 0.012 ± 0.002, post 0.031 ± 0.006 µm2) (main training effect, P < 0.001). No 
significant condition and group interactions were observed for either PLIN2 content or density. PLIN5 content 
(expressed as % of fibre stained) was significantly greater in type I fibres than type II fibres at all time points, 
irrespective of intervention (P < 0.001, Fig. 3C & D). A main effect of training was observed for PLIN5 
content, with significant increases occurring in both fibre types after training (type I fibres: SIT 2.2-fold, ET 
2.8-fold, type II fibres: SIT 2.2-fold, ET 3.4-fold, main training effect; P < 0.001, Fig. 3C & D). This finding was 
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attributed to an increase in PLIN5 density in both type I (SIT: pre 0.054 ± 0.005, post 0.079 ± 0.007 µm2, ET: 
pre 0.039 ± 0.003, post 0.107 ± 0.011 µm2) and type II fibres (SIT: pre 0.009 ± 0.001, post 0.018 ± 0.004 
µm2, ET: pre 0.005 ± 0.001, post 0.025 ± 0.005 µm2) (main training effect, P < 0.001). Again, no significant 
condition and group interaction effects were observed.  
 
We performed immunoblotting of whole muscle homogenates in order to confirm the finding of an increase in 
both PLIN2 and PLIN5 content in response to training using immunohistochemical methodology.  
Immunoblot analysis revealed a main effect of training for PLIN2 content (SIT 3.9-fold, ET 5.8-fold; P = 0.02, 
Fig 2E), with no difference between groups. PLIN5 protein expression was also increased following training 
(SIT 2.0-fold, ET 2.4-fold, main training effect; P = 0.01, Fig 3E), again with no difference between groups.  
 
Colocalisation of PLIN2 and PLIN 5 with IMTG 
Before training, the fraction of PLIN2 colocalised with IMTG in resting muscle was similar between groups 
(SIT 0.58 ± 0.04, ET 0.61 ± 0.04; P = 0.96). This relationship was unchanged in response to both training 
interventions. Pre-training, 60 min steady state exercise induced a significant reduction in the fraction of 
PLIN2 colocalised with PLIN2 (SIT 30 ± 6%, ET 23 ± 4%; main training effect, P < 0.01). This reduction was 
the result of a decrease in IMTG content and an unchanged PLIN2 content. Post-training, a significantly 
larger reduction in the fraction of PLIN2 associated with IMTG was observed in response to the exercise 
bout (SIT 37 ± 7%, ET 40 ± 4%; P = 0.01) with no difference between groups (data not shown). As a change 
in PLIN2 association with IMTG was observed following steady state exercise both before and after training, 
we investigated the number of LDs either associated (PLIN2-LD) or not associated (PLIN2-null-LD) with 
PLIN2 at each time point. Both before and after training, the number of PLIN2-LD was greater than the 
number of PLIN2-null-LD before exercise. Pre-training, 60 min steady state exercise induced a reduction in 
the number of PLIN2-LD (SIT 22 ± 10%, ET 28 ± 6%; P = 0.01, Fig. 4E & F), whereas the number of PLIN2-
null-LD was unchanged. In contrast, following training, exercise induced a significant reduction in both the 
PLIN2-LD (SIT 32 ± 6%, ET 39 ± 6%; P < 0.001) and the PLIN2-null-LD (SIT 24 ± 12%, ET 35 ± 12%; P = 
0.01, Fig. 4E & F). No group interactions were detected with either condition or time for variables of PLIN2 
and IMTG association, indicating that observations were statistically similar between groups. 
 
Prior to training, the fraction of PLIN5 colocalised with IMTG was similar between groups (SIT 0.58 ± 0.04, 
ET 0.50 ± 0.04; P = 0.20), and following both training interventions this relationship was unchanged. Pre-
training, 60 min steady state exercise significantly reduced the fraction of PLIN5 associated with IMTG (SIT 
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36 ± 4%, ET 33 ± 2%; main effect of time, P < 0.01), which was the result of a reduction in IMTG with no 
change in PLIN5 content. Following training, the exercise-induced reduction in the fraction of PLIN5 
colocalised with IMTG tended to be larger compared to pre-training, which bordered on statistical 
significance (SIT 40 ± 3%, ET 41 ± 3%; P = 0.06), and with no difference between groups (data not shown).  
As above, we subsequently investigated the absolute number of LDs either associated (PLIN5-LD) or not 
associated (PLIN5-null-LD) with PLIN5 at each time point. Pre-training, the number of PLIN5-LD was larger 
in the SIT than the ET group (P < 0.05), but no difference in the number of PLIN5-null-LD was apparent.  
Despite this discrepancy, a similar reduction in PLIN5-LD was observed in response to exercise (SIT 32 ± 
4%, ET 35 ± 4%; P < 0.01, Fig. 4G & H), with no change in the number of PLIN5-null-LD, and no difference 
between groups for either variable. Following training, exercise induced a reduction in the number of PLIN5-
LD only (SIT 38 ± 3%, ET 41 ± 5%; P < 0.01, Fig. 4G & H), with no difference between groups. 
 
Correlation analyses 
Due to the lack of group x training interactions in all variables, significant training effects were detected 
independent of exercise modality. Therefore, the data from the SIT and ET interventions (type I and type II 
fibres, pre and post training) were pooled for correlation analysis (Table 4). Both PLIN2 (R = 0.68; P < 0.001) 
and PLIN5 content (R = 0.72; P < 0.001) showed strong positive correlations with IMTG content. A very 
strong positive correlation was observed between pre-exercise IMTG concentrations and the decrease in 
IMTG content in response to 60 min steady state exercise (R = 0.81, P < 0.001). In addition, PLIN2 (R = 
0.57, P = 0.001) and PLIN5 content (R = 0.63, P < 0.001) were strongly associated with net IMTG 
breakdown. Insulin sensitivity were modestly associated with PLIN2 (R = 0.40; P = 0.02) and PLIN5 content 
(R = 0.42; P = 0.02), as well as IMTG content (R = 0.53; P = 0.01). 
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Discussion 
This is the first study to report that greater protein expression of PLIN2 and PLIN5 is associated with larger 
IMTG stores and enhanced net IMTG breakdown during exercise in type I muscle fibres following a period of 
traditional ET. This observation is consistent with our first hypothesis.  We also provide novel evidence that 
PLIN5-LDs are utilized during an acute bout of exercise irrespective of training status, whereas after a period 
of training both PLIN2-LDs and PLIN2-null-LDs are utilized during an acute bout of exercise.  In support of 
our second hypothesis, we demonstrate for the first time that like traditional ET, SIT also enhances IMTG 
content and net breakdown during 60 min of moderate intensity exercise and leads to increases in the 
protein expression of PLIN2 and PLIN5.  This common metabolic response following both SIT and ET is also 
evident in the utilization of PLIN5-LDs, PLIN2-LDs and PLIN2-null-LDs. Taken together, these adaptations 
may contribute to the mechanisms underlying the observed improvements in insulin sensitivity following SIT 
and ET. 
 
We report that ET leads to increases in IMTG content in both type I and type II fibres, and is accompanied by 
increased mitochondrial density, corroborating the findings of previous studies (Schrauwen-Hinderling et al., 
2003; Pruchnic et al., 2004; Tarnopolsky et al., 2007; Dubé et al., 2011). In addition before training, 60 min 
moderate-intensity cycling induced a small but significant decrease in IMTG in type I fibres. Importantly, we 
report that ET leads to increased rates of whole body fat oxidation during exercise at 65% pre-training 
VO2peak and that this is accompanied by large increases in net IMTG breakdown primarily in type I fibres.  
Previous studies combining IMTG content and A-V balance measurements using [U-13C]-palmitate 
demonstrate that oxidation of plasma fatty acids does not completely account for fat oxidation during 
exercise, indicating that other fat sources contribute to total fat oxidation (Sacchetti et al., 2002; van Hall et 
al., 2002; van Loon et al., 2003).  Therefore, it is reasonable to assume that fatty acids liberated through the 
net reduction in IMTG content contribute to total fat oxidation during exercise in lean but sedentary 
individuals and the IMTG contribution to total fat oxidation is increased following ET.  The latter observation 
is consistent with a number of recent training studies also examining net IMTG breakdown in a fibre type 
specific manner (Van Proeyen et al., 2011a; Van Proeyen et al., 2011b).  
 
Our data demonstrate that net IMTG breakdown during exercise is positively correlated with resting IMTG 
concentration. This corroborates the findings of several other reports in trained individuals (Coggan et al., 
2000; van Loon et al., 2003; Stellingwerff et al., 2007) and indicates that the ET-induced increase in IMTG 
content contributes to the increase in net IMTG breakdown during endurance type exercise. However, it is 
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worth noting that this is only one of a number of adaptations which likely explain the increase in IMTG 
breakdown during exercise following ET (van Loon, 2004; Shaw et al., 2010). The increase in IMTG content 
was due to a greater number of LDs rather than an increased volume of pre-existing LDs. This conclusion is 
in agreement with a previous report using transmission electron microscopy (Tarnopolsky et al., 2007). As 
smaller LDs maintain a higher surface area to volume ratio, they also provide a greater surface area for the 
interaction of lipolytic enzymes with the IMTG substrate and regulatory proteins on the LD surface. As a 
result, the mobilization of FA for oxidation during exercise would be enhanced.   
 
Using immunofluorescence microscopy we previously reported that trained athletes display a ~two-fold 
greater PLIN2 concentration in type I compared to type II muscle fibres (Shaw et al., 2009). The present data 
extends this finding to sedentary individuals, and further reveals a ~four-fold difference in PLIN5 protein 
expression when comparing type I and type II fibres. In addition, we report that ET enhances the 
intramuscular content of both PLIN2 and PLIN5, assessed through immunoblotting of whole muscle 
homogenates. The findings are partly in agreement with a recent study showing increased PLIN5, but not 
PLIN2, protein abundance in the muscle of lean and obese males following 12 weeks of endurance training 
(Peters et al., 2012) and with a cross-sectional study that reported a ~seven-fold higher PLIN5 content in 
older athletes compared to age-matched sedentary controls (Amati et al., 2011). However, our study is the 
first to examine changes in the intramuscular expression of the PLIN proteins in response to training 
interventions in a fibre type specific manner using immunofluorescence microscopy. Accordingly, we 
demonstrate that, like the changes in IMTG, the increase in PLIN2 and PLIN5 protein expression occurs in 
both type I and type II muscle fibres.  
 
In agreement with data obtained in rodent (Minnaard et al., 2009) and human skeletal muscle (Amati et al., 
2011; Peters et al., 2012), both PLIN2 and PLIN5 expression positively correlated with IMTG content 
suggesting that the expression of these PLIN proteins is proportional to IMTG content in lean, healthy 
individuals. Future research will be required to clarify if the increase in PLIN expression is the primary event 
driving the increase in IMTG content (which is the mechanism that we propose) or the consequence of the 
increase in IMTG content.  Furthermore, the fraction of IMTG associated with either PLIN2 or PLIN5 at rest 
was similar pre and post training in type I fibres (~0.64 and ~0.59, respectively). These values are consistent 
with previous reports in rat (Macpherson et al., 2012) and human skeletal muscle (Shaw et al., 2009; 
Shepherd et al., 2012). Although the physiological significance of this partial colocalisation is currently 
unknown, this finding is in agreement with a number of observations demonstrating that the protein 
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composition of LDs may vary (Wolins et al., 2005; Wolins et al., 2006b; Ducharme & Bickel, 2008; Fujimoto 
et al., 2008). To further investigate this relationship we assessed the colocalisation of these PLINs with LDs 
before and after 60 min moderate intensity endurance exercise. For each PLIN we describe two pools of 
LDs; 1) PLIN2-associated LDs (PLIN2-LD) and LDs that do not contain PLIN2 (PLIN2-null-LD) and 2) PLIN5-
associated LDs (PLIN5-LD) and LDs that do not contain PLIN5 (PLIN5-null-LD). In the untrained state, 60 
min moderate intensity endurance exercise induced a significant decrease in the number of PLIN2-LD and 
PLIN5-LD, with no change in the number of PLIN2-null-LD and PLIN5-null-LD. These observations confirm a 
recent report from our laboratory showing a preferential utilization of PLIN2-LD, and not PLIN2-null-LD, in 
response to moderate intensity endurance exercise in sedentary individuals (Shepherd et al., 2012), and 
provides novel evidence to suggest that a similar relationship exists for PLIN5. After 6 weeks ET, a 
preferential decrease in the number of PLIN2-LD and PLIN5-LD also occurred in response to 60 min 
moderate intensity endurance exercise. Interestingly, in the trained state exercise also induced a decrease in 
the content of PLIN2-null-LD after 60 min moderate intensity endurance exercise, whereas the content of 
PLIN5-null-LD did not change. This is the first observation to suggest that PLIN5 is more important than 
PLIN2 in mediating the hydrolysis of intramuscular lipid stores during exercise and is in line with emerging 
evidence concerning the precise role of PLIN5 in lipolysis in cultured cells. Indeed, PLIN5 is the only PLIN 
thus far that has been shown to bind ATGL, and its coactivator, CGI-58. In this respect, overexpression of 
PLIN5  in cultured cells recruits ATGL and CGI-58 under basal conditions, while expression of PLIN2 does 
not have this effect (Wang et al., 2011a). Furthermore, PLIN5 is phosphorylated in response to protein 
kinase A (PKA)-activation, and the expression and PKA-induced activation of PLIN5 stimulates 
triacylglycerol hydrolysis in Chinese hamster ovary cells, whereas rates of lipolysis are unaffected by PKA 
activation in cells overexpressing PLIN2 (Wang et al., 2011a; Wang et al., 2011b). It is also important to note 
that electrical stimulation and adrenaline stimulation of rat skeletal muscle (Prats et al., 2006) has been 
reported to increase the colocalisation of HSL with PLIN2. However, it is not known whether this association 
occurs in man in vivo and whether it increases rates of lipolysis. It is also worth acknowledging that we only 
assessed colocalisation of either PLIN2 or PLIN5 with the LD's, and therefore cannot discriminate LDs 
containing both PLIN2 and PLIN5 from those LDs containing only PLIN2 or PLIN5. Nevertheless, the 
observation that the number of PLIN5-LD is reduced following exercise, while no reduction occurs in the 
number of PLIN5-null-LD appears to underpin the important role of PLIN5 in LD lipolysis and subsequent 
oxidation in skeletal muscle. In line with this conclusion, observations from various cell culture models and 
rat skeletal muscle preparations suggest that PLIN5 also recruits mitochondria to the surface of LD’s, thus 
stimulating the formation of functional complexes between mitochondria and LDs (Bosma et al., 2011; Wang 
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et al., 2011b). Accordingly, PKA activation in alpha mouse liver 12 (AML12) cells expressing PLIN5 has 
recently been shown to promote triacylglycerol hydrolysis and efficient channeling of liberated fatty acids to 
the mitochondria for β-oxidation (Wang et al., 2011b). IMTG and mitochondria in skeletal muscle of 
endurance athletes are observed in close proximity (Shaw et al., 2008), and ET enhances the spatial 
interaction between IMTG and mitochondria (Tarnopolsky et al., 2007). Collectively these observations 
suggest that increased expression and PKA activation of PLIN5 may also contribute to an increased net 
IMTG breakdown during moderate intensity endurance exercise by mediating stronger interactions between 
IMTG and mitochondria. 
 
It is worth noting that there was no net IMTG breakdown in type II fibres during 60 min moderate intensity 
exercise pre or post 6 weeks of training. This observation is in line with previous studies in well-trained 
athletes performing 2-3 h moderate-intensity exercise (van Loon et al., 2003; De Bock et al., 2005; 
Stellingwerff et al., 2007).  However, PLIN2 and PLIN5 protein expression was significantly increased in type 
II fibres, raising the question as to why IMTG breakdown was not enhanced in parallel as seen in the type I 
fibres.  However, as the exercise was performed at a moderate intensity, it is likely that only a small 
proportion of the type II fibres were recruited, and this therefore may explain why no net IMTG breakdown 
was observed in type II fibres. In addition the higher PLIN2 and PLIN5 content after training in both fibre 
types may also serve other metabolic roles such as to mediate IMTG storage under non-exercise conditions.  
 
Both PLIN2 and PLIN5 also appear to play an important role in limiting rates of lipolysis in the basal state, 
since expression of either PLIN2 or PLIN5 in cultured cells reduces basal lipolytic rates compared to when 
PLIN2 is knocked down or PLIN5 is not expressed (Listenberger et al., 2007; Bell et al., 2008; Wang et al., 
2011a). Specifically, PLIN2 expression reduces the association of ATGL with the LD (Listenberger et al., 
2007; Bell et al., 2008), and PLIN5 binds ATGL under basal conditions thereby reducing its activity (Wang et 
al., 2011a). Furthermore, it has recently been shown that PLIN5 expression in AML12 cells reduces basal 
triacylglycerol hydrolysis and promotes palmitate incorporation into LD triacylglycerol (Wang et al., 2011b). If 
such mechanisms exist in vivo, these observations suggest that PLIN5 and/or PLIN2 may play a key role in 
the coupling of TAG hydrolysis to the metabolic demand for fatty acids.  As mentioned, ET increases the net 
breakdown of IMTG during exercise, therefore during an ET intervention IMTG concentrations are reduced 
on a regular basis. In addition, IMTG synthesis is upregulated in the period following IMTG-depleting 
exercise (Schenk & Horowitz, 2007).  Therefore, undertaking repeated bouts of exercise during an exercise 
training programme likely results in high rates of IMTG synthesis (Bergman et al., 2010).  As a result of this 
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combination of training adaptations in the enzymes controlling IMTG metabolism, insulin resistance-inducing-
FA metabolites have been suggested to be maintained at a lower concentration in skeletal muscle, thereby 
preserving higher insulin sensitivity in trained individuals. (Dubé et al., 2008; Dubé et al., 2011). 
 
The most well-documented adaptations to SIT are an improved VO2peak and an enhanced skeletal muscle 
oxidative capacity (reviewed Gibala et al., 2012), both of which are increased by a similar magnitude as ET 
(Burgomaster et al., 2008).  We also demonstrate that SIT and ET improve VO2peak in sedentary individuals 
as previously described (Burgomaster et al., 2008), although in the present study the improvement in VO2peak 
tended to be greater in the ET group (P = 0.064). Like ET, SIT also increased mitochondrial density, as 
previously reported (Burgomaster et al., 2008), and we provide novel data showing that SIT leads to higher 
IMTG content in type I and type II muscle fibres. In contrast to ET, no changes in whole body fat oxidation 
rates were observed following SIT.  This finding is in contrast to the findings of Burgomaster et al. (2008), 
who reported an increase in fat oxidation during exercise following SIT.  The SIT group tended to exhibit a 
lower RER than the ET group pre-training, suggesting that rates of fat oxidation were higher in the SIT group 
before training, despite the groups being matched for physical activity level, aerobic capacity and fat mass, 
and diet was controlled in the 48 h prior to the exercise bout. Nevertheless, we observe clear increases in 
IMTG breakdown in type I fibres during moderate-intensity exercise in response to SIT, suggesting that the 
source of oxidised fat is shifted from plasma fatty acids towards IMTG. Importantly, the expression of both 
PLIN2 and PLIN5 correlated with IMTG content, net IMTG breakdown in type I fibres during exercise, and 
insulin sensitivity. Therefore, the data suggests that the increase in IMTG content and net breakdown during 
exercise that results from the increased expression of PLIN2 and PLIN5 likely maintains low intramuscular 
fatty acid metabolite concentrations leading to improvements in insulin sensitivity following both ET and SIT.  
Accordingly, the present study adds to the growing body of evidence that SIT is a time-efficient exercise 
intervention to improve insulin sensitivity in healthy individuals and patient populations (Babraj et al., 2009; 
Richards et al., 2010; Hood et al., 2011; Little et al., 2011). 
 
It is important to note that the primary aim of the study was to investigate exercise training-induced increases 
in net IMTG breakdown during 60 min moderate-intensity exercise and PLIN2 and PLIN5 protein expression.  
However, it is likely that the number of subjects in the present study is not sufficiently high to detect between 
groups differences for some of the measured variables.  Therefore, although many of the training effects are 
of a similar magnitude, larger-scale studies are required to determine which exercise mode is superior in 
increasing the main metabolic outcome measures (IMTG breakdown during exercise and PLIN2 and PLIN5 
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expression) and/or in increasing whole body insulin sensitivity and aerobic exercise capacity. Studies 
involving a larger number of participants should be completed before advice can be given about which 
exercise training mode is the best for the general population and for specific patient populations. 
 
In conclusion, PLIN2 and PLIN5 expression are upregulated in response to ET, and the upregulation of 
these proteins appears to be important to facilitate the enhanced rates of net IMTG breakdown during 
exercise. In addition, PLIN2 and PLIN5 expression may contribute to an increase in IMTG content, which 
likely results in lower fatty acid metabolite concentrations, and in turn may drive the ET-induced 
improvements in insulin sensitivity. Despite the large differences in duration and energy expenditure between 
SIT and ET, we provide novel evidence indicating that SIT induces similar improvements in net IMTG 
breakdown, PLIN2 and PLIN5 protein expression, aerobic exercise capacity and insulin sensitivity as 
traditional ET.  This study, therefore, generates novel information on the mechanism by which net IMTG 
breakdown during endurance type exercise increases following both modes of exercise training, and 
provides evidence that SIT provides a time-efficient exercise alternative to achieve improvements in aerobic 
fitness and insulin sensitivity.  
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Translational Perspective 
It is well-established that individuals who perform 3-5 hours of continuous moderate-intensity exercise per 
week maintain a higher physical fitness level and have a reduced risk of developing metabolic and 
cardiovascular diseases. However, these current physical activity guidelines are not met by the majority of 
the UK population, with ‘a lack of time’ cited as the primary reason for failure to engage in regular exercise. 
Sprint interval training (SIT) may provide an effective alternative to traditional endurance-type exercise 
training (ET), with a substantial reduction in time commitment. Indeed, SIT is reported to induce similar 
increases in VO2max, mitochondrial enzyme abundance, and whole-body insulin sensitivity. Shepherd and 
colleagues show that like ET, 6 weeks of SIT increases the capacity to oxidise intramuscular triglyceride 
(IMTG) during exercise. Furthermore, they show that this adaptation may be mediated by an upregulation of 
PLIN2 and PLIN5, proteins known to be involved in regulating IMTG breakdown. The depletion and 
subsequent replenishment of the IMTG pool during exercise and recovery periods is postulated to prevent 
the accumulation of insulin resistance-inducing fatty acid metabolites. Therefore increasing IMTG oxidation is 
an important training adaptation contributing to the improvement insulin sensitivity following both ET and SIT. 
These findings add to the evidence that SIT could provide an effective exercise training mode to improve 
fitness and metabolic health in obese individuals, and elderly individuals with sarcopenia, type II diabetes 
and cardiovascular disease. Long term, large-scale studies investigating the clinical benefits of SIT in such 
populations are now warranted. 
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Tables 
 
Table 1. Subject characteristics 
 SIT ET 
 Pre Post Pre Post 
Age (yrs) 22 ± 1  21 ± 1  
Height (m) 1.74 ± 0.02  1.77 ± 0.03  
Body mass (kg) 75.1 ± 3.0 75.2 ± 3.1 70.8 ± 4.4 70.8 ± 4.5 
BMI (kg.m-2) 24.8 ± 0.8 24.8 ± 0.9 22.6 ± 1.6 22.6 ± 1.2 
VO2 peak (l.min-1) * 3.13 ± 0.15 3.37 ± 0.18 2.93 ± 0.30 3.40 ± 0.38 
VO2 peak (l.min-1.kg-1) *  41.9 ± 1.8 45.1 ± 2.3 41.7 ± 4.1 48.2 ± 5.0 
Wmax (W) * 221 ± 11 241 ± 14 218 ± 11 253 ± 16 
FFM (kg) * 52.5 ± 1.9 53.6 ± 1.8 50.7 ± 1.5 51.1 ± 2.7 
FM (kg) 14.2 ± 1.6 13.6 ± 1.5 12.3 ± 1.5 12.2 ± 1.9 
Insulin AUC (µIU.ml-1.min-1) * 8847 ± 1140 5792 ± 688 8434 ± 880 6813 ± 711 
Glucose AUC (mg.dl-1.min-1) * 17634 ± 710 14551 ± 398 16835 ± 992 14783 ± 950 
ISI-Matsuda * 3.9 ± 0.3 5.8 ± 0.4 3.7 ± 0.5 4.7 ± 0.7 
 
Data provided are means ± S.E. (n = 8 per group).  BMI body mass index, Wmax maximum workload, OGTT 
oral glucose tolerance test, FFM fat free mass, FM fat mass, AUC area under the curve, ISI insulin sensitivity 
index. * Indicates main effect for training (P < 0.05), such that Pre ≠ Post.  No interaction effects (training x 
group) were observed for any of the variables. 
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Table 2. Substrate utilization during 60 min cycling at ~65% pre-training VO2 peak 
 
SIT ET 
 Pre Post Pre Post 
Heart rate (b.min-1) * 164 ± 3 147 ± 3 165 ± 3 138 ± 4 
VO2 (l.min-1) * 2.22 ± 0.11 2.12 ± 0.12 2.19 ± 0.14 2.10 ± 0.13 
VCO2 (l.min-1) * 1.94 ± 0.09 2.01 ± 0.13 1.97 ± 0.11 1.81 ± 0.10 
CHO oxidation      
   (g.min-1) 1.61 ± 0.07 1.56 ± 0.13 1.80 ± 0.12 1.37 ± 0.07 † 
   (% of total oxidation)  62.3 ± 2.0 63.2 ± 4.4 70.9 ± 4.3 56.6 ± 3.1 † 
Fat oxidation      
   (g.min-1) 0.46 ± 0.04 0.42 ± 0.06 0.36 ± 0.07 0.49 ± 0.05 
   (% of total oxidation)  39.5 ± 1.9 38.6 ± 4.3 31.0 ± 4.3 45.1 ± 3.1 † 
RER 0.88 ± 0.01 0.88 ± 0.01 0.90 ± 0.01 0.86 ± 0.01 † 
 
 
Values obtained during 60 min of moderate-intensity cycling at ~65% pre-training VO2 peak.  Data provided 
are means ± S.E. (n = 8 per group).  RER respiratory exchange ratio, CHO carbohydrate.  * Main effect for 
training (P < 0.05) such that Pre ≠ Post (no significant differences between training interventions).  † 
Interaction effect (training x group; P < 0.05), such that the effect of ET was significantly different from the 
effect of SIT. 
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Table 3. Effect of 6 weeks of SIT or ET on fibre type specific mitochondrial content 
COX expression SIT ET 
(fluorescence intensity) Pre Post Pre Post 
Type I fibres 54.1 ± 4.6 74.4 ± 4.0† 60.1 ± 7.7 81.5 ± 5.9† 
Type II fibres* 41.1 ± 3.0 56.8 ± 3.5† 42.4 ± 4.8 60.4 ± 5.1† 
 
Mitochondrial density, quantified from immunofluorescence images of COX in type I and type II fibres 
obtained before and after 6 weeks of SIT or ET.  Values are presented as means ± S.E. (n = 8 per group).  * 
Main fibre effect (P < 0.05 vs. type I fibres).  † Main training effect (P < 0.05 vs. pre-training). 
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Table 4. Bivariate correlation analysis 
 IMTG Net IMTG breakdown Insulin sensitivity 
PLIN2 0.68‡ 0.57‡ 0.40* 
PLIN5 0.72‡ 0.63‡ 0.42* 
IMTG  0.81‡ 0.53† 
 
 
IMTG, PLIN2 and PLIN5 represent resting content. Net IMTG breakdown refers to absolute change in IMTG 
concentration from pre to post-exercise. Values represent Pearson’s squared correlation coefficients (R 
values) for relationships between variables. Due to the lack of group x training interactions in all variables, it 
was assumed that the exercise training was driving the changes independent of exercise modality. 
Therefore, the data from both intervention groups was pooled for correlation analysis. Significant 
correlations: *P < 0.05, †P < 0.01, ‡P < 0.001. 
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Figure legends 
 
Figure 1.  Effect of 6 weeks of SIT and ET on fibre type specific IMTG content and net IMTG 
breakdown during exercise. 
Representative immunofluorescence images of IMTG (stained red) in combination with WGA to identify the 
cell border (stained blue) in skeletal muscle, pre (A) and post (B) 6 weeks of SIT.  Type I fibres are indicated 
with a “I”, all other fibres are assumed type II fibres.  White bar = 50µm.  Images (C) and (D) display the 
ORO signal obtained after the intensity threshold was applied during quantitation (showing the LDs in white), 
before and after SIT, respectively.  IMTG content, quantified from immunofluorescence images of oil red O-
stained muscle sections, before (Pre-Training) and after (Post-Training) 6 weeks of SIT (closed bars) or ET 
(open bars).  IMTG content was measured before (PreEx) and after (PostEx) 60 min steady state cycling, 
and net IMTG breakdown calculated (Breakdown), in type I (E) and type II fibres (F).  Values are presented 
as means ± S.E. (n = 8 per group).  * Main effect of training intervention (P < 0.05 vs. pre-training). 
 
Figure 2.  Effect of 6 weeks of SIT and ET on fibre type specific PLIN2 expression. 
Representative immunofluorescence images of PLIN2 (stained red) in combination with WGA to identify the 
cell border (stained blue) in skeletal muscle, pre (A) and post (B) 6 weeks of SIT.  Type I fibres are indicated 
with a “I”, all other fibres are assumed type II fibres.  White bar = 50µm.  PLIN2 expression, quantified from 
immunofluorescence images of PLIN2, in type I and type II fibres obtained before (C)  and after (D) 6 weeks 
of SIT (closed bars) or ET (open bars).  PLIN2 expression quantified from immunofluorescence images 
correlated with PLIN2 expression determined following immunoblotting of whole muscle homogenates (E).  
Values are presented as means ± S.E. (n = 8 per group).  * Main effect of fibre type (P < 0.05 vs. type I 
fibres).  † Main effect of training intervention (P < 0.05 vs. pre-training). 
 
Figure 3.  Effect of 6 weeks of SIT and ET on fibre type specific PLIN5 expression. 
Representative immunofluorescence images of PLIN5 (stained green) in combination with WGA to identify 
the cell border (stained blue) in skeletal muscle, pre (A) and post (B) 6 weeks of SIT.  Type I fibres are 
indicated with a “I”, all other fibres are assumed type II fibres.  White bar = 50µm.  PLIN5 expression, 
quantified from immunofluorescence images of PLIN5, in type I and type II fibres obtained before (C)  and 
after (D) 6 weeks of SIT (closed bars) or ET (open bars).  PLIN5 expression quantified from 
immunofluorescence images correlated with PLIN5 expression determined following immunoblotting of 
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whole muscle homogenates (E).  Values are presented as means ± S.E. (n = 8 per group).  * Main effect of 
fibre type (P < 0.05 vs. type I fibres).  † Main effect of training intervention (P < 0.05 vs. pre-training). 
  
Figure 4.  Analysis of the colocalisation of PLIN2 and PLIN5 with LDs pre and post 60 min steady 
state cycling, before and after 6 weeks of SIT or ET. 
Representative immunofluorescence images of PLIN5 (A), IMTG (B), and the merged images (C) with the 
yellow areas describing regions of overlap between PLIN5 and IMTG images.  The yellow objects were then 
extracted (to measure the number of PLIN5-LDs) (D), and the number subtracted from the total number of 
LDs to quantify the number of PLIN5-null-LD.  The same procedure was used to obtain values of 
colocalisation between PLIN2 and IMTG.  White bar = 5µm.  The number of PLIN2-LD (closed bars) and 
PLIN2-null-LD (open bars) were quantified before (PreEx) and after exercise (PostEx), prior to (E) and 
following (F) training in both the SIT and ET groups.  The same analysis was repeated for PLIN5 for pre (G) 
and post training (H).  * Main effect of exercise bout (P < 0.05 vs. pre-exercise). 
 
Supplementary figure 1.  Confirmation of PLIN5 antibody specificity. 
The specificity of the PLIN2 antibody was confirmed in a competition experiment where a PLIN5 recombinant 
peptide (Novus Biologicals, Cambridge, UK) was incubated with the antibody, and subsequently the punctate 
pattern typical of PLIN5 positive staining (A) was removed (B).  White bar = 50µm. 
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Figure 2 
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Supplementary figure 1. 
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